vs
LivaNova PLC（LIVN）与ROYAL GOLD INC（RGLD）财务数据对比。点击上方公司名可切换其他公司
ROYAL GOLD INC的季度营收约是LivaNova PLC的1.0倍（$375.3M vs $360.9M），ROYAL GOLD INC净利率更高（24.9% vs 8.6%，领先16.4%），ROYAL GOLD INC同比增速更快（85.3% vs 12.1%），过去两年ROYAL GOLD INC的营收复合增速更高（58.8% vs 10.6%）
LivaNova PLC是一家深耕医疗设备领域的企业，总部位于英国，核心业务为研发心脏外科及神经调控类医疗设备。该公司由美国Cyberonics公司与意大利Sorin公司于2015年以27亿美元对价合并成立，目前在纳斯达克挂牌交易，股票代码为LIVN。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业，收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益，资产覆盖黄金、白银、铜等品类，业务遍及多地区，无需直接承担采矿运营风险。
LIVN vs RGLD — 直观对比
营收规模更大
RGLD
是对方的1.0倍
$360.9M
营收增速更快
RGLD
高出73.1%
12.1%
净利率更高
RGLD
高出16.4%
8.6%
两年增速更快
RGLD
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $360.9M | $375.3M |
| 净利润 | $30.9M | $93.6M |
| 毛利率 | 65.2% | 64.6% |
| 营业利润率 | 11.8% | 56.2% |
| 净利率 | 8.6% | 24.9% |
| 营收同比 | 12.1% | 85.3% |
| 净利润同比 | -44.7% | -12.8% |
| 每股收益（稀释后） | $0.57 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LIVNRGLD
| Q4 25 | $360.9M | $375.3M | ||
| Q3 25 | $357.8M | $252.1M | ||
| Q2 25 | $352.5M | $209.6M | ||
| Q1 25 | $316.9M | $193.4M | ||
| Q4 24 | $321.8M | $202.6M | ||
| Q3 24 | $318.1M | $193.8M | ||
| Q2 24 | $318.6M | $174.1M | ||
| Q1 24 | $294.9M | $148.9M |
净利润LIVNRGLD
| Q4 25 | $30.9M | $93.6M | ||
| Q3 25 | $26.8M | $126.8M | ||
| Q2 25 | $27.2M | $132.3M | ||
| Q1 25 | $-327.3M | $113.5M | ||
| Q4 24 | $55.9M | $107.4M | ||
| Q3 24 | $33.0M | $96.2M | ||
| Q2 24 | $16.3M | $81.2M | ||
| Q1 24 | $-41.9M | $47.2M |
毛利率LIVNRGLD
| Q4 25 | 65.2% | 64.6% | ||
| Q3 25 | 68.4% | 73.6% | ||
| Q2 25 | 67.8% | 72.6% | ||
| Q1 25 | 69.7% | 69.4% | ||
| Q4 24 | 68.2% | 70.3% | ||
| Q3 24 | 70.8% | 66.6% | ||
| Q2 24 | 68.7% | 64.7% | ||
| Q1 24 | 70.3% | 58.4% |
营业利润率LIVNRGLD
| Q4 25 | 11.8% | 56.2% | ||
| Q3 25 | 15.1% | 64.4% | ||
| Q2 25 | 15.4% | 67.7% | ||
| Q1 25 | 15.3% | 63.6% | ||
| Q4 24 | 11.5% | 65.9% | ||
| Q3 24 | 11.2% | 61.3% | ||
| Q2 24 | 12.6% | 58.6% | ||
| Q1 24 | 5.5% | 50.7% |
净利率LIVNRGLD
| Q4 25 | 8.6% | 24.9% | ||
| Q3 25 | 7.5% | 50.3% | ||
| Q2 25 | 7.7% | 63.1% | ||
| Q1 25 | -103.3% | 58.7% | ||
| Q4 24 | 17.4% | 53.0% | ||
| Q3 24 | 10.4% | 49.7% | ||
| Q2 24 | 5.1% | 46.6% | ||
| Q1 24 | -14.2% | 31.7% |
每股收益（稀释后）LIVNRGLD
| Q4 25 | $0.57 | $1.04 | ||
| Q3 25 | $0.49 | $1.92 | ||
| Q2 25 | $0.50 | $2.01 | ||
| Q1 25 | $-6.01 | $1.72 | ||
| Q4 24 | $1.04 | $1.63 | ||
| Q3 24 | $0.60 | $1.46 | ||
| Q2 24 | $0.30 | $1.23 | ||
| Q1 24 | $-0.78 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.6M | $233.7M |
| 总债务越低越好 | $376.1M | — |
| 股东权益账面价值 | $1.2B | $7.2B |
| 总资产 | $2.6B | $9.5B |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资LIVNRGLD
| Q4 25 | $635.6M | $233.7M | ||
| Q3 25 | $646.1M | $172.8M | ||
| Q2 25 | $593.6M | $248.2M | ||
| Q1 25 | $738.4M | $240.8M | ||
| Q4 24 | $428.9M | $195.5M | ||
| Q3 24 | $346.4M | $127.9M | ||
| Q2 24 | $329.2M | $74.2M | ||
| Q1 24 | $309.2M | $137.9M |
总债务LIVNRGLD
| Q4 25 | $376.1M | — | ||
| Q3 25 | $434.5M | — | ||
| Q2 25 | $430.6M | — | ||
| Q1 25 | $628.2M | — | ||
| Q4 24 | $627.0M | — | ||
| Q3 24 | $625.5M | $0 | ||
| Q2 24 | $624.5M | $50.0M | ||
| Q1 24 | $623.8M | — |
股东权益LIVNRGLD
| Q4 25 | $1.2B | $7.2B | ||
| Q3 25 | $1.2B | $3.4B | ||
| Q2 25 | $1.1B | $3.3B | ||
| Q1 25 | $1.0B | $3.2B | ||
| Q4 24 | $1.3B | $3.1B | ||
| Q3 24 | $1.3B | $3.0B | ||
| Q2 24 | $1.2B | $3.0B | ||
| Q1 24 | $1.2B | $2.9B |
总资产LIVNRGLD
| Q4 25 | $2.6B | $9.5B | ||
| Q3 25 | $2.6B | $4.5B | ||
| Q2 25 | $2.5B | $3.6B | ||
| Q1 25 | $2.6B | $3.5B | ||
| Q4 24 | $2.5B | $3.4B | ||
| Q3 24 | $2.5B | $3.3B | ||
| Q2 24 | $2.5B | $3.3B | ||
| Q1 24 | $2.5B | $3.3B |
负债/权益比LIVNRGLD
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | 0.00× | ||
| Q2 24 | 0.50× | 0.02× | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.4M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $50.2M | — |
| 自由现金流率自由现金流/营收 | 13.9% | — |
| 资本支出强度资本支出/营收 | 8.9% | — |
| 现金转化率经营现金流/净利润 | 2.67× | 2.58× |
| 过去12个月自由现金流最近4个季度 | $173.3M | — |
8季度趋势，按日历期对齐
经营现金流LIVNRGLD
| Q4 25 | $82.4M | $241.7M | ||
| Q3 25 | $85.1M | $174.0M | ||
| Q2 25 | $62.9M | $152.8M | ||
| Q1 25 | $24.0M | $136.4M | ||
| Q4 24 | $78.7M | $141.1M | ||
| Q3 24 | $51.0M | $136.7M | ||
| Q2 24 | $43.4M | $113.5M | ||
| Q1 24 | $10.0M | $138.3M |
自由现金流LIVNRGLD
| Q4 25 | $50.2M | — | ||
| Q3 25 | $62.2M | — | ||
| Q2 25 | $47.8M | — | ||
| Q1 25 | $13.2M | — | ||
| Q4 24 | $68.3M | — | ||
| Q3 24 | $32.8M | — | ||
| Q2 24 | $31.2M | — | ||
| Q1 24 | $3.6M | — |
自由现金流率LIVNRGLD
| Q4 25 | 13.9% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 13.6% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 21.2% | — | ||
| Q3 24 | 10.3% | — | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | 1.2% | — |
资本支出强度LIVNRGLD
| Q4 25 | 8.9% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 3.4% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | 2.2% | — |
现金转化率LIVNRGLD
| Q4 25 | 2.67× | 2.58× | ||
| Q3 25 | 3.18× | 1.37× | ||
| Q2 25 | 2.32× | 1.15× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | 1.41× | 1.31× | ||
| Q3 24 | 1.55× | 1.42× | ||
| Q2 24 | 2.65× | 1.40× | ||
| Q1 24 | — | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |
